Oticon Own SI™
Hearing Loss
CommercialActive
Key Facts
About Oticon
Oticon, a cornerstone of the Danish Demant Group, is a mission-driven medical device company with a 120-year legacy of innovating in hearing care. Its core strategy is built on the BrainHearing™ paradigm, which focuses on supporting the brain's natural listening processes rather than merely amplifying sound, a differentiator supported by its own independent research facility. The company achieves global scale through a vast, professional-led distribution network across 130 countries, commercializing a mature portfolio of AI-enabled hearing aids and accessories designed to mitigate the broader health risks associated with hearing loss.
View full company profileTherapeutic Areas
Other Hearing Loss Drugs
| Drug | Company | Phase |
|---|---|---|
| ADB-105 | Adolore BioTherapeutics | Pre-clinical |
| Next-Generation Connectivity & Digital Health Features | Advanced Bionics | Development |
| Next-Gen AI Hearing Aids | Starkey | Development/Commercialization |
| Oticon Zeal™ | Oticon | Commercial Launch |
| Oticon Intent™ | Oticon | Commercial |
| Oticon Jet PX | Oticon | Commercial |